Cronos Group Inc.
corporate_fare Company Profile
Cronos Group Inc. (NASDAQ:CRON) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 7 items for CRON at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-06, rated 8/10. Across its 7 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for CRON spans 10-Q, 8-K, 10-K.
Recent high-impact activity:
- Cronos Group Swings to Q2 Profit on 58% Revenue Surge; New Anti-Dumping Probe Looms
- Cronos Group Posts Record Q2 Revenue, Swings to Profit, and Flags New Israeli Anti-Dumping Probe
- Cronos Expands $50M Share Buyback Program to Toronto Stock Exchange, Secures US Trading Exemption
- Cronos Group Reports Strong Q1 Results, Initiates New $50M Share Buyback, Benefits from US Cannabis Rescheduling
- Cronos Group Reports Strong Q1 Results, Authorizes $50M Share Buyback
Financial Snapshot
Short Interest & Short Volume
4.11 days to coverFINRA reported short interest of 3,253,266 shares in CRON as of the September 15, 2026 settlement, a 0.3% increase from the prior period — about 4.1 days to cover at its recent average daily volume. On October 2, 2026, 22.2% of CRON volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.